Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’study)
11/03/2024
Aymon, R., Mongin, D., Bergstra, S. A., Choquette, D., Codreanu, C., De Cock, D., ... & Lauper, K.
Annals of the rheumatic diseases.
https://doi.org/10.1136/ard-2023-224670
doi: 10.1136/ard-2023-224670